The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 15, 2014

Filed:

Mar. 29, 2012
Applicants:

Martin Youngjin Pettersson, Waterford, CT (US);

Douglas Scott Johnson, Mystic, CT (US);

Chakrapani Subramanyam, South Glastonbury, CT (US);

Christopher John O'donnell, Mystic, CT (US);

Christopher William AM Ende, Mystic, CT (US);

Benjamin Adam Fish, Groton, CT (US);

Michael Eric Green, Mystic, CT (US);

Patrick Bradley Mullins, East Lyme, CT (US);

Cory Michael Stiff, Salem, CT (US);

Tuan Phong Tran, Ledyard, CT (US);

Thayalan Navaratnam, Ledyard, CT (US);

Inventors:

Martin Youngjin Pettersson, Waterford, CT (US);

Douglas Scott Johnson, Mystic, CT (US);

Chakrapani Subramanyam, South Glastonbury, CT (US);

Christopher John O'Donnell, Mystic, CT (US);

Christopher William am Ende, Mystic, CT (US);

Benjamin Adam Fish, Groton, CT (US);

Michael Eric Green, Mystic, CT (US);

Patrick Bradley Mullins, East Lyme, CT (US);

Cory Michael Stiff, Salem, CT (US);

Tuan Phong Tran, Ledyard, CT (US);

Thayalan Navaratnam, Ledyard, CT (US);

Assignee:

Pfizer Inc., New York, NY (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/551 (2006.01); A61K 31/695 (2006.01); A61K 31/4985 (2006.01); A61P 25/00 (2006.01); A61P 25/18 (2006.01); A61P 25/28 (2006.01); C07D 401/04 (2006.01); C07D 471/04 (2006.01); C07F 7/10 (2006.01);
U.S. Cl.
CPC ...
Abstract

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I as defined herein. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.


Find Patent Forward Citations

Loading…